Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2020 Filed Aug 18, 2020 21:03 UTC |
BOUSBIB ARIDirector · See Remarks
|
OtherEmployee Stock Option (Right to Buy) · Derivative | 69,120 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001478242-20-000060 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,200 Underlying: Common Stock · 69,120 shares Expires 2020-12-01 Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 21:03 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 69,120 | $161.66 | $11,173,939.20 |
DisclosureSEC source: 0001478242-20-000060 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,035 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2020. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $160.48 to $162.88 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 21:03 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 69,120 | $8.34 | $576,460.80 |
DisclosureSEC source: 0001478242-20-000060 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 721,155 Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 6,145 | $0.00 Strike: $131.82 | $0.00 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · derivative · entry 13 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,291 Underlying: Common Stock · 6,145 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 14,262 | $0.00 Strike: $95.23 | $0.00 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · derivative · entry 12 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,132 Underlying: Common Stock · 14,262 shares Expires 2028-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $64.67 | $0.00 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · derivative · entry 11 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2026-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,475 | $0.00 Strike: $64.93 | $0.00 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · derivative · entry 10 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,475 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,508 | $0.00 Strike: $53.26 | $0.00 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · derivative · entry 9 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,508 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Disposition to issuerCommon Stock | 13,523 | $160.54 | $2,170,982.42 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 8 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,470 Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
SaleCommon Stock | 6,884 | $160.04 | $1,101,715.36 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 7 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,993 F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $160.00 to $160.15 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionCommon Stock | 6,145 | $131.82 | $810,033.90 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 6 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionCommon Stock | 14,262 | $95.23 | $1,358,170.26 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 5 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
SaleCommon Stock | 13,483 | $160.47 | $2,163,617.01 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 4 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,470 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $160.00 to $160.81 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionCommon Stock | 3,500 | $64.67 | $226,345.00 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 3 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionCommon Stock | 2,475 | $64.93 | $160,701.75 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 11, 2020 21:02 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionCommon Stock | 7,508 | $53.26 | $399,876.08 |
DisclosureSEC source: 0001478242-20-000059 · edgar.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 5, 2020 21:02 UTC |
Bruehlman Ronald ESee Remarks
|
PurchaseCommon Stock | 10,000 | $159.94 | $1,599,400.00 |
DisclosureSEC source: 0001478242-20-000058 · edgar.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,751 F2 · price: The price reported in Column 4 is a weighted average price for shares purchased in multiple transactions. The purchase prices range from $159.75 to $160.04 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:02 UTC |
Bruehlman Ronald ESee Remarks
|
GrantCommon Stock | 16,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000058 · edgar.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,751 F1 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on August 3, 2021. Read SEC document |
| July 28, 2020 Filed Jul 29, 2020 16:42 UTC |
TPG Group Holdings (SBS) Advisors, Inc.Former Director
TPG Advisors VI, Inc.Former Director
TPG Advisors V, Inc.Former Director
TPG Biotech Advisors, Inc.Former Director
BONDERMAN DAVIDFormer Director
COULTER JAMES GFormer Director
|
SaleCommon Stock | 2,919,051 | $159.12 | $464,479,395.12 |
DisclosureSEC source: 0001387131-20-006834 · iqv-form4_072820.xml · nonDerivative · entry 1 TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · Former Director TPG Advisors VI, Inc. · CIK 0001433038 · Former Director TPG Advisors V, Inc. · CIK 0001425876 · Former Director TPG Biotech Advisors, Inc. · CIK 0001666545 · Former Director BONDERMAN DAVID · CIK 0000860866 · Former Director COULTER JAMES G · CIK 0001099776 · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 0 F1 · ownership.nature: David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. ("Group Advisors"), (ii) TPG Advisors VI, Inc. ("Advisors VI"), (iii) TPG Advisors V, Inc. ("Advisors V") and (iv) TPG GP Advisors, Inc. (as successor to TPG Biotech Advisors, Inc.) ("TPG GP Advisors" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the "Reporting Persons"). F2 · ownership.nature: Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., (ii) TPG FOF V-A, L.P. and (iii) TPG FOF V-B, L.P. TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P. F3 · ownership.nature: TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P. and (ii) managing member of TPG Iceberg Co-Invest LLC. Advisors V is the general partner of TPG Quintiles Holdco II, L.P. TPG GP Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the "TPG Funds"). Each of the TPG Funds directly held shares of Common Stock of IQVIA Holdings Inc. F4 · ownership.nature: Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may have been deemed to have beneficially owned the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any. F5 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 21:09 UTC |
BOUSBIB ARIDirector · See Remarks
|
OtherEmployee Stock Option (Right to Buy) · Derivative | 46,080 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001478242-20-000051 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,320 Underlying: Common Stock · 46,080 shares Expires 2020-12-01 Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 21:09 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 46,080 | $160.00 | $7,372,800.00 |
DisclosureSEC source: 0001478242-20-000051 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,035 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2020. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 21:09 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 46,080 | $8.34 | $384,307.20 |
DisclosureSEC source: 0001478242-20-000051 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 698,115 Read SEC document |
| July 16, 2020 Filed Feb 4, 2021 22:23 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 192 | $149.68 | $28,738.56 |
DisclosureSEC source: 0001478242-21-000005 · wf-form5_161247740132282.xml · derivative · entry 3 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,399 Underlying: Common Stock · 192 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 05, 2020 Filed Jul 7, 2020 22:26 UTC |
McDonnell Michael R.EVP and CFO
|
Tax withholdingCommon Stock | 2,762 | $141.52 | $390,878.24 |
DisclosureSEC source: 0001478242-20-000040 · primary_doc.xml · nonDerivative · entry 1 MCDONNELL MICHAEL R · CIK 0001121897 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,966 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
OtherEmployee Stock Option (Right to Buy) · Derivative | 46,080 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001478242-20-000036 · edgar.xml · derivative · entry 6 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,400 Underlying: Common Stock · 46,080 shares Expires 2020-12-01 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
OtherEmployee Stock Option (Right to Buy) · Derivative | 118,797 | $0.00 Strike: $15.11 | $0.00 |
DisclosureSEC source: 0001478242-20-000036 · edgar.xml · derivative · entry 5 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 118,797 shares Expires 2020-12-01 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 164,877 | $150.11 | $24,749,686.47 |
DisclosureSEC source: 0001478242-20-000036 · edgar.xml · nonDerivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,035 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2020. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $150.00 to $151.53 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 46,080 | $8.34 | $384,307.20 |
DisclosureSEC source: 0001478242-20-000036 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,912 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 118,797 | $15.11 | $1,795,022.67 |
DisclosureSEC source: 0001478242-20-000036 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 770,832 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
OtherEmployee Stock Option (Right to Buy) · Derivative | 19,443 | $0.00 Strike: $15.11 | $0.00 |
DisclosureSEC source: 0001478242-20-000035 · edgar.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,797 Underlying: Common Stock · 19,443 shares Expires 2020-12-01 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 19,443 | $150.00 | $2,916,450.00 |
DisclosureSEC source: 0001478242-20-000035 · edgar.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,035 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2020. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $150.00 to $150.01 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:35 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 19,443 | $15.11 | $293,783.73 |
DisclosureSEC source: 0001478242-20-000035 · edgar.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,478 Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:04 UTC |
DANHAKL JOHN GDirector
|
GrantCommon Stock | 1,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000031 · edgar.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,970 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:03 UTC |
Burt CarolDirector
|
GrantCommon Stock | 1,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000030 · edgar.xml · nonDerivative · entry 1 Burt Carol · CIK 0001493926 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,970 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in Carol Burt Hilliard Revocable Trust. Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:07 UTC |
LEONARD JOHN MDirector
|
GrantCommon Stock | 1,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000033 · edgar.xml · nonDerivative · entry 1 LEONARD JOHN M. · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,744 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:08 UTC |
Rittenmeyer Ronald ADirector
|
GrantCommon Stock | 1,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000034 · edgar.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,277 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 06, 2020 Filed May 8, 2020 21:05 UTC |
GOGGINS COLLEEN ADirector
|
GrantCommon Stock | 1,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000032 · edgar.xml · nonDerivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,251 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 06, 2020 Filed Feb 4, 2021 22:23 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 214 | $134.01 | $28,678.14 |
DisclosureSEC source: 0001478242-21-000005 · wf-form5_161247740132282.xml · derivative · entry 2 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,207 Underlying: Common Stock · 214 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 21:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,600 | $0.00 Strike: $21.20 | $0.00 |
DisclosureSEC source: 0001478242-20-000019 · edgar.xml · derivative · entry 2 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 6,600 shares Expires 2021-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 21:00 UTC |
EVANISKO MICHAEL JDirector
|
Exercise / conversionCommon Stock | 6,600 | $21.20 | $139,920.00 |
DisclosureSEC source: 0001478242-20-000019 · edgar.xml · nonDerivative · entry 1 EVANISKO MICHAEL J · CIK 0001258567 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 11,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Options to purchase shares held in the Michael J. Evanisko 2007 Revocable Trust. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 22:01 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 259 | $141.36 | $36,612.24 |
DisclosureSEC source: 0001478242-20-000018 · edgar.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,470 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:02 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 2,191 | $163.43 | $358,075.13 |
DisclosureSEC source: 0001478242-20-000017 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 22:03 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 5,688 | $165.09 | $939,031.92 |
DisclosureSEC source: 0001478242-20-000015 · edgar.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,191 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $165.00 to $165.54 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:18 UTC |
CONNAUGHTON JOHNDirector
|
GiftCommon Stock | 5,764 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005478 · doc4.xml · nonDerivative · entry 2 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:18 UTC |
CONNAUGHTON JOHNDirector
|
OtherCommon Stock | 68,228 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-005478 · doc4.xml · nonDerivative · entry 1 CONNAUGHTON JOHN · CIK 0001213395 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 617,484 F3 · kind: On February 19, 2020, certain of the Bain Capital Entities distributed 68,228 shares of common stock to one or more members or partners of the Bain Capital Entities, including 5,764 shares of common stock to Mr. Connaughton, in connection with certain charitable gifts made by such members or partners. F1 · ownership.nature: Represents shares of common stock held directly by Bain Capital Integral Investors 2008, L.P. ("Integral 2008"), BCIP TCV, LLC ("BCIP TCV") and BCIP Associates-G ("BCIP-G" and, collectively, the "Bain Capital Entities"). F2 · ownership.nature: Bain Capital Investors, LLC ("BCI") is the ultimate general partner of Integral 2008 and governs the investment strategy and decision-making process with respect to investments held by each of BCIP TCV and BCIP-G. John Connaughton is a Managing Director of BCI. By virtue of the relationships described in this footnote, Mr. Connaughton may be deemed to share voting and dispositive power with respect to all of the shares of common stock held by the Bain Capital Entities. Mr. Connaughton disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:05 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 18,224 | $0.00 Strike: $78.21 | $0.00 |
DisclosureSEC source: 0001478242-20-000016 · edgar.xml · derivative · entry 4 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,224 shares Expires 2027-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:05 UTC |
STAUB W RICHARDSee Remarks
|
Disposition to issuerCommon Stock | 8,674 | $165.42 | $1,434,853.08 |
DisclosureSEC source: 0001478242-20-000016 · edgar.xml · nonDerivative · entry 3 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,729 Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:05 UTC |
STAUB W RICHARDSee Remarks
|
SaleCommon Stock | 14,550 | $163.77 | $2,382,853.50 |
DisclosureSEC source: 0001478242-20-000016 · edgar.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,403 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $162.84 to $164.91 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 22:05 UTC |
STAUB W RICHARDSee Remarks
|
Exercise / conversionCommon Stock | 18,224 | $78.21 | $1,425,299.04 |
DisclosureSEC source: 0001478242-20-000016 · edgar.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 19:00 UTC |
TPG Advisors VI, Inc.Director
TPG Advisors V, Inc.Director
TPG Biotech Advisors, Inc.Director
BONDERMAN DAVIDDirector
COULTER JAMES GDirector
|
SaleCommon Stock | 2,996,172 | $164.30 | $492,271,059.60 |
DisclosureSEC source: 0001387131-20-001902 · iqv-form4_021320.xml · nonDerivative · entry 1 TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · Director TPG Advisors VI, Inc. · CIK 0001433038 · Director TPG Advisors V, Inc. · CIK 0001425876 · Director TPG Biotech Advisors, Inc. · CIK 0001666545 · Director BONDERMAN DAVID · CIK 0000860866 · Director COULTER JAMES G · CIK 0001099776 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 2,919,051 F1 · ownership.nature: David Bonderman and James G. Coulter are sole shareholders of each of (i) TPG Group Holdings (SBS) Advisors, Inc. ("Group Advisors"), (ii) TPG Advisors VI, Inc. ("Advisors VI"), (iii) TPG Advisors V, Inc. ("Advisors V") and (iv) TPG Biotech Advisors, Inc. ("Biotech Advisors" and, together with Group Advisors, Advisors VI, Advisors V and Messrs. Bonderman and Coulter, the "Reporting Persons"). F2 · ownership.nature: Group Advisors is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of each of (i) TPG GenPar V Advisors, LLC, (ii) TPG GenPar VI Advisors, LLC and (iii) TPG Biotechnology GenPar III Advisors, LLC. TPG GenPar V Advisors, LLC is the general partner of TPG GenPar V, L.P., which is the general partner of each of (i) TPG Partners V, L.P., which directly holds 1,043,851 shares of Common Stock ("Common Stock") of IQVIA Holdings Inc. (the "Issuer"), (ii) TPG FOF V-A, L.P., which directly holds 2,731 shares of Common Stock, and (iii) TPG FOF V-B, L.P., which directly holds 2,202 shares of Common Stock. F3 · ownership.nature: TPG GenPar VI Advisors, LLC is the general partner of TPG GenPar VI, L.P., which is the general partner of TPG Partners VI, L.P., which directly holds 1,044,654 shares of Common Stock. TPG Biotechnology GenPar III Advisors, LLC is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P., which directly holds 43,101 shares of Common Stock. Advisors VI is the (i) general partner of TPG FOF VI SPV, L.P., which directly holds 4,129 shares of Common Stock, and (ii) managing member of TPG Iceberg Co-Invest LLC, which directly holds 359,173 shares of Common Stock. F4 · ownership.nature: Advisors V is the general partner of TPG Quintiles Holdco II, L.P., which directly holds 398,364 shares of Common Stock. Biotech Advisors is the general partner of TPG Quintiles Holdco III, L.P. (together with TPG Partners V, L.P., TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG Biotechnology Partners III, L.P., TPG FOF VI SPV, L.P., TPG Iceberg Co-Invest LLC and TPG Quintiles Holdco II, L.P., the "TPG Funds"), which directly holds 20,846 shares of Common Stock. F5 · ownership.nature: Because of the relationship between the Reporting Persons and the TPG Funds, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of the TPG Funds. Each Reporting Person and each of the TPG Funds disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's or such TPG Fund's pecuniary interest therein, if any. F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.